Thursday, 7 December 2023
  
Login

Australia's most trusted
source of pharma news

Thursday, 7 December 2023
Ascott IQVIA
Ascott IQVIA
TGA: See you in court

The regulatory watchdog is taking a company and its former Director to court for illegally advertising prescription-only  products on its website and social media page.

Big pharma 'refreshes' brand
Upgrades look and tagline but keeps logo the same
TODAY
Chem Warehouse rumours swirl
Trading holt for Sigma - is the pharmacy giant going public?
TODAY
J&J unveils mega 2030 plan
Suite of mega-blockbusters expected by the end of the decade
TODAY
JPD
JPD
Five new drugs hit review list
Anticipated blockbusters including another gene therapy
6 December
How flexible is your pharma?
How working conditions stack up across the industry
5 December
Ex-MA exec's death rocks industry
Sudden passing of former communications manager
4 December
Companies hit PBAC with big ask
MSD and BMS have big hopes for their top-selling drugs
4 December
Fleishman
Fleishman
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (14)

Clinical & Medical, R&D (7)

Regulatory, Pharmacovigilance & QA (6)

Executive Roles (2)

Other (24)

Blockbuster to crack new market
Already huge drug expanding into untapped space
TODAY
Future in doubt for patient group
Founder says high-profile organisation is winding up
TODAY
Simply the best in Medical Affairs
MAPA Excellence Award winners 2023 reavealed
6 December
Another win for KRAS drug
Aussie-led study shows combo potential in big market
6 December
Top rewards for pharma stars
What's the best recognition for 'a job well done'?
6 December
Why Novartis is sitting pretty
Which fast-growing meds have pumped up revenue?
6 December
Real reform or window dressing?
NZ's Pharmac facing change but funding problem remains
6 December
Roche takes a shot in obesity
Buys best-in-class potential for mega-market
5 December
Pharmacy behaviours unpacked
New report reveals drop in pharmacy visits this year
5 December
Familiar face joins MA Board
This top ex-public servant brings decades of Govt experience
5 December
Drug safety probe rolls into 2024
EMA's safety committee asks companies for more information
5 December
Is this the next big thing in cancer?
Company acquires bacteria-based delivery platform
5 December
AbbVie nabs potential blockbuster
Picks up first-in-class drug on strong growth trajectory
4 December
Gonged PR firm joins global team
International network offers greater opportunities
4 December
PIF jobs
PIF jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.